investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Kwok Kin Wong

In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap

Trachea, bronchus and lung

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology

A. Mcgarry Houghton

Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer

Trachea, bronchus and lung

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung

Elisabeth D Martinez

Characterization of the biological activities of novel epigenetic modulators

Trachea, bronchus and lung

Pathology

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology

Peter S Hammerman

Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer

Trachea, bronchus and lung